as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹20.57
Change
+0.36 (1.78%)
Open
₹20.26
Prev. Close
₹20.21
Day High
₹20.8
Day Low
₹20.05
Volume Analysis
Traded
74,653
Delivered
58,314
Delivery %
78.11%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹21.64 | ₹21.22 | ₹20.89 | ₹20.47 | ₹20.14 | ₹19.72 | ₹19.39 |
| Fibonacci | ₹21.22 | ₹20.93 | ₹20.76 | ₹20.47 | ₹20.18 | ₹20.01 | ₹19.72 |
| Camarilla | ₹20.78 | ₹20.71 | ₹20.64 | ₹20.47 | ₹20.5 | ₹20.43 | ₹20.36 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-6.58%
1 Week
-0.53%
1 Month
+3.94%
3 Months
-3.56%
6 Months
-1.2%
1 Year
-6.54%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Company Overview
Source: Screener.in (Consolidated figures) — data as of 17 Nov 2026. Not investment advice.
TopFund Analysis
Icicipramc - Iciciqty30 lands in the middle of the pack on TopFund's composite fundamentals check, at 61/100. The strongest factor is Risk & Volatility (70/100), while Liquidity (50/100) is the weakest area to weigh before deciding.
TopFund Score — Fundamentals Quality
61/100 — AverageData confidence: 56/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Risk & Volatility
Liquidity
Not investment advice — an automated read of public fundamentals data, for research context only.
Which Mutual Funds Hold Icicipramc - Iciciqty30?
Frequently Asked Questions about Icicipramc - Iciciqty30
Icicipramc - Iciciqty30 (QUAL30IETF) closed at ₹20.57 on NSE on 19 November 2026, up 0.36 (1.78%) from the previous close.
Icicipramc - Iciciqty30 trades on the NSE (National Stock Exchange of India) under the symbol QUAL30IETF.
Icicipramc - Iciciqty30 has a TopFund Quality Score of 61/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Icicipramc - Iciciqty30?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.